Literature DB >> 23957209

Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1.

Asataro Yamamoto1, Ryu Takeya, Masaki Matsumoto, Keiichi I Nakayama, Hideki Sumimoto.   

Abstract

Superoxide production by Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1 (Nox activator 1) and is markedly enhanced upon cell stimulation with phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC). The mechanism underlying PMA-induced enhancement of Nox1 activity, however, remains to be elucidated. Here we show that, in response to PMA, Noxo1 undergoes phosphorylation at multiple sites, which is inhibited by the PKC inhibitor GF109203X. Among them, Thr341 in Noxo1 is directly phosphorylated by PKC in vitro, and alanine substitution for this residue reduces not only PMA-induced Noxo1 phosphorylation but also PMA-dependent enhancement of Nox1-catalyzed superoxide production. Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Noxa1, an interaction that participates in Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1; this serine is the major residue that is phosphorylated by PKA in vitro. Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1 activity in different manners. STRUCTURED DIGITAL ABSTRACT: Noxo1 binds to p22phox by pull down (1, 2, 3) Noxo1 binds to Noxo1 by pull down (View interaction) Noxa1 binds to Noxo1 by pull down (1, 2, 3, 4, 5).
© 2013 FEBS.

Entities:  

Keywords:  NADPH oxidase; Nox1; Noxa1; Noxo1; protein kinase A; protein kinase C

Mesh:

Substances:

Year:  2013        PMID: 23957209     DOI: 10.1111/febs.12489

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

Review 1.  Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.

Authors:  M Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  The analysis of antioxidant expression during muscle atrophy induced by hindlimb suspension in mice.

Authors:  Tran-Non Nuoc; Suhee Kim; Sun Hee Ahn; Jin-Sil Lee; Byung-Ju Park; Tae-Hoon Lee
Journal:  J Physiol Sci       Date:  2016-03-12       Impact factor: 2.781

3.  Peroxiredoxin 6 (Prdx6) supports NADPH oxidase1 (Nox1)-based superoxide generation and cell migration.

Authors:  Jaeyul Kwon; Aibing Wang; Devin J Burke; Howard E Boudreau; Kristen J Lekstrom; Agnieszka Korzeniowska; Ryuichi Sugamata; Yong-Soo Kim; Liang Yi; Ilker Ersoy; Stefan Jaeger; Kannappan Palaniappan; Daniel R Ambruso; Sharon H Jackson; Thomas L Leto
Journal:  Free Radic Biol Med       Date:  2016-04-14       Impact factor: 7.376

Review 4.  Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.

Authors:  Alessia Parascandolo; Mikko O Laukkanen
Journal:  Antioxid Redox Signal       Date:  2018-11-22       Impact factor: 8.401

5.  Regulation of NADPH oxidase 5 by protein kinase C isoforms.

Authors:  Feng Chen; Yanfang Yu; Steven Haigh; John Johnson; Rudolf Lucas; David W Stepp; David J R Fulton
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

Review 6.  NADPH oxidase in brain injury and neurodegenerative disorders.

Authors:  Merry W Ma; Jing Wang; Quanguang Zhang; Ruimin Wang; Krishnan M Dhandapani; Ratna K Vadlamudi; Darrell W Brann
Journal:  Mol Neurodegener       Date:  2017-01-17       Impact factor: 14.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.